Cardiol Therapeutics Inc Class A
Drug Manufacturers - Specialty & Generic
Healthcare
CRDL
82.61 M shares
NASDAQ US
traded
14 Aug 2025
listed
no
open
1.17
52 week high
2.97
high
1.35
52 week low
0.00
low
1.16
growth
-33.33 %
previous Close
1.35
P/E ratio
market cap
84.25 M
div yield
0
usd
Jun 2025
qoq
revenue
0.00 %
net incoming
0.00 %
eps
0.00 %
0.00 %
eps surprise
100.00 %
net profit margin
0.00 %
0.00 %
operating incoming
0.00 %
net change in cash
0.00 %
cash on hand
0.00 %
cost of revenue
0.00 %
top top